Phase III SOLE: Continuous vs Intermittent Letrozole After Adjuvant Endocrine Therapy in Early HR+ Breast Cancer

Slideset - Extended intermittent letrozole did not improve DFS or other efficacy outcomes compared with continuous dosing.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research